PC 01

Drug Profile

PC 01

Latest Information Update: 27 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Asahi Glass; Seikagaku Corporation
  • Developer Asahi Glass; Kaken Pharmaceutical; Meiji Seika Kaisha; Seikagaku Corporation
  • Class Oxidoreductases
  • Mechanism of Action Superoxide dismutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Amyotrophic lateral sclerosis; Ulcerative colitis

Most Recent Events

  • 27 May 2002 Discontinued - Phase-II for Amyotrophic lateral sclerosis in Japan (unspecified route)
  • 27 May 2002 Discontinued - Phase-II for Ulcerative colitis in Japan (unspecified route)
  • 01 Mar 2001 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top